Merck's Keytruda Stakes Its Claim To First-Line Use In Advanced Cervical Cancer

Top-Line KEYNOTE-826 Results

 
• By John Davis
  
cervical cancer cells
cervical cancer cells • Source: Alamy

More from Clinical Trials

More from R&D